Created by: Heiko Enderling, Renee Brady-Nicholls

Issue 174: We use clinical data of intermittent, adaptive prostate cancer hormone therapy to simulate tumor growth and treatment response dynamics. With that, we can predict possible patient-specific response trajectories to subsequent treatment cycles and recommend treatment adaptations when necessary. Click here to read more.